A B S T R A C T When purified antihemophilic factor (Factor VIII) was rechromatographed on 4% agarose in 0.15 M NaCl or 1.0 M NaCi, a single protein peak, containing both procoagulant activity and von Willebrand factor activity, as defined by ristocetin-induced platelet aggregation, was eluted in the void volume. Purified Factor VIII immediately lost about 30% of its procoagulant activity when dissolved in 0.25 M CaC12, and when rechromatographed on 4% agarose in 0.25 M CaCl2, the protein peak and von Willebrand factor activity remained coincident in the void volume; however, most of the remaining procoagulant activity was eluted after the void volume. The elution position of Factor VIII procoagulant activity from 4% agarose in 0.25 M CaCl2, and hence its apparent molecular weight, varied with the protein concentration applied to the column; at low protein concentrations it was eluted close to the inner volume. Yet on Sephadex G-200 in 0.25 M CaCl, the protein and procoagulant activity were eluted together in the void volume. These observations suggested that the Factor VIII procoagulant activity was not eluting according to size or shape, but was adsorbing to some extent to the agarose. Isolated activity peak material from the 0.25 M CaCl2 columns contained protein and had a typical ultraviolet spectrum. Even at high concentrations, the protein contained no thrombin, Factors IX, X, or Xa activity, or detectable phospholipid. In addition to Factor VIII procoagulant activity, which could be inactivated by a human antibody to Factor VIII, the activity peak protein also contained von Willebrand factor activity. Like native Factor VIII and the A preliminary report of this work was given at the 47th Scientific Session of the American Heart Association, 
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INTRODUCTION
Human antihemophilic factor (Factor VIII) eluted near the void volume when plasma or Factor VIII concentrates were chromatographed on 2-4% agarose in dilute, neutral buffers (1) (2) (3) (4) (5) (6) (7) . The s25 . value of 16.3 for Factor VIII in the potent dispersing reagent guanidine hydrochloride appeared to rule out a noncovalently linked subunit structure (4) . Recent studies of purified Factor VIII showed that it is a glycoprotein with a molecular weight of about one million (6) and that it is composed of disulfide-bound subunits which contain carbohydrate (5) (6) (7) (8) . Sodium dodecyl sulfate gel electrophoresis, sedimentation equilibrium ultracentrifugation, and isoelectric focusing experiments performed in our laboratory (7) indicated that these covalently linked subunits are in fact identical with respect to size and electrical charge. In the absence of reducing agents such as 8-mercaptoethanol, none of the above studies reported any evidence for small dissociable subunits, even in the presence of dispersing reagents such as high concentrations of urea, The Journal of Clinical Investigation Volume 57 April 1976-925937guanidine hydrochloride, or sodium dodecyl sulfate. Furthermore, in most of the above investigations, some idea of the purity of the Factor VIII preparation under study was provided.
Despite these biochemical studies of highly purified preparations of Factor VIII, debate about the molecular structure of Factor VIII continues. Several investigators (9) (10) (11) (12) (13) (14) (15) (16) have recently reported that Factor VIII activity in plasma or plasma concentrates can be dissociated by chromatography in certain high ionic strength buffers, particularly 0.25 M CaCl2, to yield a high molecular weight "carrier protein" and a low molecular weight "active subunit." The carrier protein eluted in the void volume while the small active subunit containing the procoagulant (PC)' activity eluted later. The observation that both purified Factor VIII and the void volume protein from the salt dissociation studies corrected the platelet defect in von Willebrand's disease led to the suggestion that the carrier protein contained the von Willebrand factor (vWF) activity (13) (14) (15) (16) (17) (18) (19) (20) . These studies have been hampered by an absence of criteria of purity and the lack of biochemical characterizations of the protein(s) associated with the PC or vWF activities.
Using electrophoretically and immunologically homogeneous Factor VIII, we have studied its chromatographic behavior in 0.15 M NaCl, 1.0 M NaCl, and 0.25 M CaC12. Evidence is presented which is not consistent with the "carrier protein-active subunit" hypothesis for Factor VIII structure. Our results, instead, support a covalently linked subunit structure for Factor VIII and suggest that the molecule has both PC and vWF activities.
METHODS
Reagents. Reagent grade chemicals were used without further purification. Except for dissociation studies, 0.1 M e-aminocaproic acid and 0.02%o sodium azide were used routinely in all buffers. All solutions were buffered to pH against unadsorbed rabbit antiserum. The Factor VIII samples were stored at -20°C as 0.05-to 1.0-ml aliquots until needed. Yield data and degree of purification at each step have been published previously from this laboratory (7) .
Electrophoresis. Sample preparation and polyacrylamide gel electrophoresis in sodium dodecyl sulfate (SDS) was carried out essentially as described earlier (7) . Gels were stained for protein or carbohydrate, destained, and stored as previously described (7).
Chromatography studies. Ultra-high purity Factor VIII was rechromatographed on 4% agarose in the following buffers: 0.15 M NaCl-0.05 M Tris, 1.0 M NaCl-0.05 M Tris, or 0.25 M CaCl2-0.01 M NaCl-0.05 M Tris, each of which was pH 7.35. Columns were calibrated with Blue Dextran (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) and pumped negatively with a peristaltic pump to maintain constant flow. Plastic columns of different dimensions (0.9 X 11, 0.9 X 26, 0.9 X 55, and 2.5 X 98 cm) were used for these experiments; in each instance the sample volume was 2-3%o of the column volume, and-the fractions were approximately the same volume as the applied sample. All of these columns gave satisfactory resolution of the protein peak from the Factor VIII procoagulant activity peak when 0. 25 (27) was prepared by incubating 1 ml of Factor VIII (5 absorbance U at 280 nm) with 0.5 CTA (Committee on Thrombolytic Agents) U of purified (28) human plasminogen (22 CTA U/mg) and 5 Ploug U of urokinase at 370C for 24 h. The reaction was monitored by Factor VIII activity assays and by SDS-gel analysis of the proteolytically degraded and p-mercaptoethanol-reduced Factor VIII.
Platelet studies. Siliconized glassware or plasticware was used throughout these studies. Venous blood was collected by a two-syringe technique and anticoagulated with 1 part 3.2% sodium citrate: 9 parts blood. Platelet-rich plasma was prepared by centrifuging the anticoagulated blood for 10 min at 300 g and 25°C. A platelet pellet was prepared by recentrifuging the platelet-rich plasma for 10 min at 10,000 g and 25°C. The platelet pellet was then washed three times with a 4-ml vol of 0.15 M NaCl-0.05 M Tris-0.02 M EDTA and resuspended in 0.15 M NaCl-0.05 M Tris. The platelet count was adjusted to --50,000/mm8 with the same buffer. Platelet aggregation studies were performed using a Chrono-Log aggregometer (Chrono-Log Corp., Broomall, Pa.) attached to a Heath Servo-Recorder (Heath Co., Benton Harbor, Mich.). Ristocetin (1, 040 Bacillus subtilus bactericidal U/mg, kindly supplied by Dr. Grant H. Barlow, Abbott Laboratories, Chicago, Ill.) was dissolved in 0.15 M NaCl-0.05 M Tris to a final concentration of 15 mg/ml. Before each aggregation assay, the recorder was adjusted to 90% transmittance with buffer and to 10%o transmittance with the platelet suspension. To 0.4 ml of platelet suspension, 0.05 ml of Factor VIII test sample was added; after 1 min had elapsed for base-line stabilization, 0.05 ml of ristocetin solution was added and the transmittance was recorded until it became constant.
To compute the vWF activity, the maximum slope of percent transmittance versus time was determined and taken RESULTS The Factor VIII used in the studies reported here had a specific activity of about 25 U/absorbance U at 280 nm and a specific vWF activity of about 1,000 U/absorbance U of purified Factor VIII protein. The ultra-high purity Factor VIII gave a single immunoprecipitin line when tested against unadsorbed rabbit antiserum by double diffusion or immunoelectrophoresis. In addition, when purified nonreduced Factor VIII was analyzed by SDSgel electrophoresis, only the top of the gel stained for protein and no other bands were seen; after reduction by fi-mercaptoethanol, a major protein band of 195,000 daltons and two or three very minor bands ranging from 180,000-160,000 daltons were observed. These latter bands, which were frequently observed when purified Factor VIII preparations were reduced and analyzed on overloaded SDS gels, have been identified (27) as early degradation intermediates of the 195,000-dalton subunit when Factor VIII was digested by plasmin. It is very difficult to isolate native Factor VIII without minor amounts of plasmin-degraded Factor VIII since both the native and minimally degraded forms of Factor VIII are similar in size and elute in the void volume from 4% agarose.
Chromatography of Factor VIII in 0.15 M NaCI. Fig.   1 shows the pattern observed when 0.4 absorbance U of purified Factor VIII was rechromatographed on 4% agarose in 0.15 M NaCl. A single sharp peak of protein with both PC and vWF activities was eluted in the void volume. Both the PC and vWF activities were proportional to the protein concentration of this peak. To the right of the chromatogram are SDS-5% polyacrylamide gel patterns of the nonreduced and reduced void volume protein. In the absence of reducing reagent, only the very top of the gel stained for protein and no bands entered the SDS 5% gel, which excludes proteins with molecular weights greater than about 400,000 daltons. After reduction by P-mercaptoethanol, a major band corresponding to a molecular weight of 195,000 daltons was always observed; occasionally two minor bands of -160,000-130,000 daltons were observed and when present, these constituted less than 5% of the total protein applied.
Chromatography of Factor VIII in 1 M NaCI. Since PC activity has been reported to dissociate from the void volume protein when partially purified Factor VIII is chromatographed on 4% agarose in 0.8-1 M NaCl (11, 14) , the effect of 1 M NaCl on purified Factor VIII was examined. Fig. 2 shows that the elution profile was the same as that observed in 0.15 M NaCl when the same amount of protein was applied. The protein as well as the PC and vWF activities eluted as a single sharp peak in the void volume. Before reduction, the protein in the void volume fractions did not enter a SDS 5% gel; after reduction, however, a single band corresponding to the 195,000-dalton subunit of the native molecule was observed. No lower molecular weight bands were observed on the SDS gels before or after reduction.
Chromatography of Factor VIII in 0.25 M CaCls. When approximately 2.5 absorbance U of purified Factor VIII was rechromatographed on 4% agarose in 0.25 M CaClh, the results were very different from those obtained in 0.15 or 1.0 M NaCl. As shown in Fig. 3 , a protein peak similar to that observed at either concentration of NaCi eluted in the void volume while most of the PC activity eluted in later fractions. The recoveries of protein and PC activity from the CaCb columns were about 80% and 70% with respect to the applied sample made to 0.25 M in CaCh. There was no loss of procoagulant activity with time in the aliquot of the applied sample assayed at the beginning and end of each chromatography experiment. In general, the bulk of the PC activity eluted in a region of the chromatogram where no protein peak could be detected by absorbance at 280 or 210 nm, by Elution Volume, ml FIGuRE 2 4% agarose gel filtration of highly purified Factor VIII in 1.0 M NaCl (column size: 0.9 X 26 cm). The protein, PC activity and vWF activity eluted in the void volume. The SDS-5% gel electrophoretic patterns of the nonreduced (NR) and reduced (R) protein are identical to those in Fig. 1 . the Lowry method or by fluorescence. Most of the vWF activity eluted with the void volume protein peak, although vWF activity could also be detected beneath the PC activity peak. For example, in the chromatogram in Fig. 3 , vWF activity is expressed on a scale 10' times smaller than protein absorbance. Without concentration, the vWF activity of the fraction eluting at 8 ml is about 17 U/ml, or 17 times that contained in 1 ml of normal plasma. Throughout the elution profile, vWF activity was proportional to the absorbance at 280 nm. Thus, contrary to the reports of others (13, 14) , vWF activity could also be easily demonstrated in the PC activity peak, particularly after fractions beneath the PC activity peak had been pooled as indicated by the horizontal bar in Fig. 3 Effect of protein concentration on the chromatography of Factor VIII in 025 M CaCi. To determine whether the shifted PC activity peak eluted at a constant position, and therefore, as a function of its size and shape, the effect of the protein concentration of the applied sample on the elution pattern of Factor VIII in 0.25 M CaClh was examined. Although these studies were performed under identical conditions with a constant sample volume of 0.4 ml on the same carefully calibrated column, the elution position of the activity peak varied with protein concentration. As shown in Fig. 4 at two different protein concentrations. In both cases the protein peak eluted in the void volume and the PC activity peak eluted later. At the lower protein concentration shown in the upper panel, the PC activity eluted significantly later when compared to the higher protein concentration shown in the lower panel.
was applied, the PC activity peak eluted at a volume of 27.5 ml; however, when 1.5 absorbance U were applied, the PC activity peak eluted at 20.9 ml, a difference of 6.6 ml. Usually the void volume protein peaks in 0.25 M CaCL or 1.0 M NaCl were somewhat broader than those observed in 0.15 M NaCl; however, the broadening could not be related to the amount of protein applied to the column. Fig. 5 Fig. 7 shows that although Factor VIII specific activity in 0.25 M CaCla increased as protein concentration decreased, the increase in specific activity was still less than that observed when compared to the samples in 0.15 M NaCl. Assays for protein, phospholipid, and polyethylene glycol. After concentration by lyophilization and reconstitution in small volumes of buffer, the total protein recovered in the PC activity peak from 4% agarose in 0.25 M CaCl2 was usually about 1% of the applied protein when determined by absorbance at 280 nm or by the Lowry method. Although not quantitated rigorously, it was our impression that larger columns gave poorer yields of the activity peak protein. The ultraviolet spectrum of the lyophilized, reconstituted activity peak material was typical for a protein, with a broad shoulder at about 270 nm and a strong peak below 200 nm.
Factor VIII contained no measurable phosphate by the ascorbic-molybdate method, which should have detected 1 mole or more of phosphate per mole of Factor VIII. Hence, it is reasonable to exclude the possibility that the shifted PC activity peak is related to the separation identical results were obtained on a 0.9 X 26-cm column). Protein and PC activity were eluted in the void volume. of noncovalently-bound phospholipid alone or a phospholipid-rich Factor VIII complex. The possibility that polyethylene glycol, alone or in concert with trace Factor VIII or other clotting factors, could account for the shifted peak of PC activity in 0.25 M CaCla was discounted since Factor VIII purified without using polyethylene glycol still gave a shifted activity peak. In addition, aliquots of fractions from the chromatography of polyethylene glycol alone in 0.25 M CaCl2 had no effect on the clotting time of the Factor VIII assay.
Assays of other clotting factors. After concentration and reconstitution to an absorbance at 280 nm of 0.20, the PC activity peak was tested for other clotting factors. The activity peak protein gave clotting times identical to buffer controls in specific assays for Factors IX, X, and Xa. Furthermore, no thrombin activity was detected in an assay system which was sensitive to as little as 0.2 NIH U/ml. Similar results were obtained when selected activity peak fractions were examined before concentration. Hence, the PC activity resolved by agarose gel filtration in 0.25 M CaCla is not due to clotting factors which might mimic Factor VIII activity.
Comparison of native Factor VIII to the void volume protein and the activity peak protein. While others have reported that the activity peak protein has PC but not vWF activity (13, 14) , in our experiments it had both A Covalent Subunit Structure for Human Antihemophilic Factor tive specific protein, however, had a specific Factor VIII activity to those of much greater than that of native Factor VIII and rerotein. The tained some PC activity even after dialysis, lyophilizathe specific tion, and reconstitution. ctivity peak The specific vWF activity was computed from the ristocetin-induced platelet aggregation data as described in the Methods section. it1ional5sub0 (PC activity of 0.37 U/ml) and the activity peak sample reciateds (PC activity of 0.68 U/ml) were completely inactivated within 1 min. Native Factor VIII (PC activity of 1.60 U/ml) lost 88% of its activity after incubating for 1 min with the antibody and 99% of its activity after 72 min.
SDS-gel electrophoresis of the activity peak protein. To date, no structural information has been reported for the activity peak protein. Fig. 8 shows the SDS-5% gel electrophoretic patterns for native Factor VIII, plasmindigested Factor VIII, and the void volume protein and activity peak protein recovered from the CaCl2-agarose column. The nonreduced SDS-gel patterns of the void volume protein and PC activity peak protein were identical to that of native Factor VIII, all showed protein that did not enter a SDS-5% polyacrylamide gel. Fig. 8 also shows the SDS-gel electrophoretic patterns for the same protein samples, but after reduction by 3-mercaptoethanol. Both native Factor VIII and the void volume protein were reduced to a single 195,000-dalton peptide. The activity peak protein, however, was reduced into five major subunit polypeptides which had molecular weights of 195,000, 136,000, 82,000, 60,000, and 53,000 daltons. Two minor bands with molecular weights of 115,000 and 30,000 daltons were also present. SDS-gel analyses of several different preparations of the PC activity peak protein showed that the bands of 82,000, 60,000, and 53,000 daltons were the most prominent. As shown in Fig. 9 , when SDS gels of reduced samples with the same protein concentration from different areas of the elution pattern were analyzed, the greatest intensity of the multiple polypeptide band pattern (gel g, Fig. 8 ) did in fact coincide with the activity peak. Fractions subsequent to the activity peak did not contain protein.
While the reduced gel of plasmin-treated Factor VIII is clearly different from that of the activity peak protein, there are enough qualitative similarities to suggest that the SDS-gel pattern of the reduced PC activity peak protein also results from proteolytic cleavage of the 195,000-dalton subunit of native Factor VIII. As a control, fractions from the region of the 4% agarose-0.15 M NaCl chromatogram of Factor VIII that corresponded to the activity peak region from the 4% agarose-0.25 M CaCI2 column were also concentrated and analyzed by SDS-gel electrophoresis. At best a trace band could be seen occasionally in the 80,000-to 60,000-dalton region after reduction. Unlike elutions from the agarose-CaCl2 columns, however, usually no protein or activity was recovered from this area of the chromatogram when 0.15 M NaCl was used as the eluent.
DISCUSSION
The central issue in the current controversy about the molecular structure of Factor VIII is whether the molecule has a covalent structure and contains both PC and vWF activities or whether the molecule is composed of two noncovalently joined subunits, one of which is small and contains the PC activity and the other of which is large and contains the vWF activity. Obviously the controversy is not a moot point since each model has important and quite different implications to the genetics as well as to the future therapy of both hemophilia and von Willebrand's disease.
In the present study, we were unable to confirm recent reports (9, 11, 14) that Factor VIII dissociates when filtered through 4% agarose in 0.80-1.0 M NaCl. Instead, the protein, PC, and vWF activities eluted together in the void volume just as they did in 0.15 M NaCl. Admittedly, highly purified Factor VIII was used in our studies while only partially purified Factor VIII or crude concentrates were used in those studies where dissociation was observed (9, 11, 14) . While perhaps it is possible that some change in the Factor VIII molecule occurred during its purification that prevented dissociation, this explanation is not likely, since SDS-gel analyses showed only the expected bands before or after reduction. In view of the property of 1% SDS-5 M urea to dissociate the noncovalent structure of a large spectrum of proteins, the active subunit, reportedly around 100,000 daltons in molecular weight, should have been apparent as a band within a SDS 5% gel, provided that it was present in high enough concentrations and that it stained with Coomassie blue.
When purified Factor VIII was rechromatographed on 4% agarose in 0.25 M CaCI2, a protein peak similar to that observed on the NaCl columns eluted in the void volume and as others have noted (9-16), the peak of PC activity eluted later. Contrary to expectations, the elution position of the PC activity peak was very sensitive to the protein concentration of the applied sample, despite the use of identical conditions and the same column. Figs. 4 and 5 clearly demonstrate that the PC activity peak was included farther into the column as the protein concentration of the applied sample decreased. Such variation has not been mentioned in reports by other investigators who have observed the "dissociation" of PC activity from the void volume protein in the presence of 0.25 M CaChI. Probably our observations account for the widely different molecular weights for the PC activity peak protein reported by the same investigators ( 10, 12) as well as by different investigators (9) . A protein or peptide of constant molecular weight should elute at the same position when identical chromatographic conditions are employed unless: (a) complete dissociation to a smaller species occurs only at low protein concentrations, above which monomeric forms become bound to each other or to a carrier protein; or (b) the elution position of the PC activity peak is not simply a function of molecular size, but instead results from varying degrees of adsorption to the agarose gel. Elutlon Voume , mN FIGURE 10 Gel filtration of highly purified Factor VIII on 4% agarose in 0.25 M CaCla (column size: 2.5 X 98 cm). This is the best resolution of the PC activity peak from the void volume protein; however, this degree of resolution was not reproducible. Furthermore, exceedingly low yields of PC activity peak protein were recovered from this size column, presumably due to adsorption to the agarose in the presence of 0.25 M CaCl2.
Several considerations appear to discount the first possibility. Data from the present study as well as from others (10) (11) (12) 14) suggest that at least 70% of the PC activity becomes dissociated from the void volume protein in 0.25 M CaCl2. Since all investigators agree that the carrier protein is essentially excluded by the agarose, any undissociated carrier protein-active subunit complex would be eluted in the void volume. If the PC activity peak shifted farther into the column because of increased dissociation of the active subunit from the carrier protein, one would expect the completely dissociated active subunit to be eluted at a volume at least as great as that observed for the most dilute protein solution applied. For the examples given in Figs. 4 and 5, this volume is 27.5 ml while the void volume for the same column is 15.4 ml. With such great separation between the void volume and the elution volume of the PC activity peak, a peak of PC activity corresponding to the undissociated carrier protein-active subunit complex should elute in the void volume, and a second peak of PC activity corresponding to the fully dissociated subunit should elute much later. Hence, the observation of only a single, symmetrical activity peak is not consistent with the explanation of increasing dissociation of the active subunit from the carrier protein at low protein concentrations. If, however, the active subunit has a molecular weight of 100,000-200,000 daltons and aggregates with itself, an aggregate of six or more active subunits might be expected to elute in the void volume. Smaller aggregates would then be expected to elute after the void volume. Assuming that the size of the aggregate is strictly a function of protein concentration, one would expect to produce a distribution of aggregate sizes at each concentration, with the smaller aggregates eluting later from the column. A single peak of activity that shifts on dilution of the applied sample is therefore consistent with the formation of smaller aggregates of active subunits. Our Sephadex G-200 chromatography data, however, discount this hypothesis that the varying elution position of the PC activity peak results from varying stages of dissociation or aggregation and instead support the second hypothesis that different degrees of adsorption lead to the varying elution positions. If the PC activity peak protein were as small as proposed by other investigators (10, 12) , it should also dissociate from the void volume protein on Sephadex G-200, which has an exclusion limit of about 400,000 daltons. However, when purified Factor VIII was rechromatographed on Sephadex G-200 in 0.25 M CaCl2, both protein and PC activity always eluted together in the void volume. The observations that the PC activity peak was eluted in the void volume on Sephadex G-200 and at varying volumes on 4% agarose suggest that the PC activity peak protein is large and that adsorption to the agarose in the presence of 0.25 M CaCl is occurring to some extent. Our results, however, cannot be reconciled with the report of others (12) that a small active subunit is included in Sephadex G-150 in 0.25 M CaCl2.
To date, the stoichiometry of the large carrier protein and active subunit complex has not been addressed by any investigators, despite the finding of little or no protein beneath the displaced PC activity peak separated on agarose in 0.25 M CaCh2. Fig. 10 , a chromatogram of purified Factor VIII filtered through 4% agarose in 0.25 M CaCl2, shows that a protein peak with a maximum absorbance of 0.700 U eluted sharply in the void volume the PC activity peak eluted much later and had a flat absorbance of --0.001 U. If it is assumed that the absorbance at 280 or 210 nm is proportional to the protein concentration, then the weight ratio of carrier protein to active subunit is 700: 1 for phospholipid, Factors IX, X, and Xa and thrombin were negative. The PC activity peak protein does, however, possess many properties heretofore associated with Factor VIII. It has both PC and vWF activities and furthermore the PC activity is totally abolished by a human Factor VIII antibody. The observation that, unlike the void volume protein, it is very soluble in water (-2 absorbance U at 280 nm) discounts the possibility that the PC activity peak protein is merely void volume protein that "tails" into the PC activity peak.
Measurement of the vWF activity is a sensitive method of detecting native or modified Factor VIII. Native Factor VIII, thrombin-inactivated Factor VIII, and Factor VIII inactivated by a human antibody all retain essentially full vWF activity (27) . Even after 24 h of plasmin digestion, which results in degradation of its subunit structure, Factor VIII still retains -80% of its vWF activity. Hence, as shown in Table I , the similarity of the specific vWF activities of the void volume and activity peak proteins to that of native Factor VIII in 0.25 M CaCI2 suggests that both are native or modified forms of Factor VIII. Factor VIII PC activity is extremely sensitive (27) to activation or inactivation by a variety of chemical or enzymatic means. Thus, the large differences among the specific PC activities of native Factor VIII in CaCI2, the void volume protein, and the activity peak protein are not surprising. The void volume protein appears to be a nonactive form of Factor VIII, possibly inactivated by Ca++. The activity peak protein has a higher specific activity than native Factor VIII in CaCl2, possibly because of activation by a protease. Therefore, the different PC/vWF ratios for native Factor VIII in CaCh, the void volume protein, and the activity peak protein reflect only the respective differences in the specific PC activities, since the specific vWF activities were about the same for the three cases.
The first structural information on the activity peak protein is provided by our SDS-gel electrophoretic data. Like native Factor VIII and the void volume protein, the activity peak protein contains material that does not enter a SDS 5% gel in the absence of reducing reagent. This result indicates that the activity peak protein is large and does not contain noncovalently bonded subunits smaller than --400,000 daltons. On reduction, the void volume protein and native Factor VIII show identical gel patterns, which contain only the 195,000 dalton subunit; however, the gel pattern for the reduced activity peak protein is different. It shows a series of seven bands, the molecular weights of which range from 195,000 to 30,000 daltons. The higher molecular weight bands of the reduced activity peak protein varied in intensity from one preparation to another but they were always less intense than the lower molecular weight bands of 82,000, 60,000, and 53,000 daltons. The SDS-gel pattern of the reduced activity peak was reminiscent of patterns resulting from plasmin degradation of Factor VIII not exposed to CaCL. There are, however, major differences between SDS-gel patterns of the reduced activity peak protein and plasmin-degraded Factor VIII. For example, the activity peak protein has more high molecular weight bands and fewer bands overall than plasmin-treated Factor VIII. In addition, treatment of Factor VIII by plasmin in several different ratios always resulted in a loss and never an enhancement of Factor VIII activity. These observations indicate that the SDS-gel pattern for the reduced activity peak protein was not due to degradation of factor VIII by plasmin. Quite possibly thrombin, which is known to enhance Factor VIII PC activity (6, 7, 14, 27) , could be the protease involved. For example, a small amount of Factor VIII might be partially activated by thrombin in vivo or during the early stages of plasma processing. Since thrombin-modified Factor VIII subunits would still be covalently joined by disulfide bonds to form a macromolecule with a molecular weight of one million or more, a small amount of thrombin-modified Factor VIII should copurify with native Factor VIII; however, the modifications might be such that the thrombin-activated Factor VIII easily adsorbs to agarose in the presence of 0.25 M CaCl2. This suggestion that the PC activity peak protein represents a modified, partially activated form of Factor VIII concentrated by adsorption onto agarose in 0.25 M CaCl2 does not conflict with reports that thrombin produces no detectable modification of Factor VIII (6, 7). Instead, the earlier reports probably reflect the inability of the SDS-gel technique to detect a modified form of Factor VIII which constitutes less than 1% of purified Factor VIII preparations isolated by agarose chromatography in 0.15 M NaCl. Finally, the report that thrombin can activate the PC ac-tivity peak protein (29, 30) could be explained by further activation of an already partially modified Factor VIII species.
In conclusion, our results indicate that the PC activity peak of protein is large, > 400,000 daltons, and is composed of several disulfide-bound nonidentical subunits. The activity peak protein does not filter true to size in that it appears to interact with the agarose gel in 0.25 M CaCh. It is suggested that the PC activity peak protein is a modified form of native Factor VIII on the basis of its apparent size when nonreduced, its multiple band pattern after reduction, and its possession of vWF activity as well as PC activity. Our data from the CaCh studies, suggest that only a very small proportion of circulating Factor VIII protein is active, possibly as a result of thrombin action, whereas the remainder has perhaps been inactivated by certain proteolytic enzymes, or remains in a precursive state, or is inhibited directly by 0.25 M CaCl2. The following schematic depicts the interpretation of our data.
Native Factor VIII (a) has PC and vWF activities in 0.15 M NaCI. 
